XGN (Exagen) Short Interest


XGN Exagen Inc XGN
58 GF Score
Price $4.52
GF Value $3.00
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Exagen Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XGN vs FONR, BNR, BDSX: Short Interest Comparison

For the Diagnostics & Research subindustry, Exagen's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exagen Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Exagen's Short Interest distribution charts can be found below:

* The bar in red indicates where Exagen's Short Interest falls into.


XGN
58GF Score
Exagen Inc XGN
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Exagen (XGN) Overvalued in 2026?

Based on GuruFocus' analysis, Exagen stock appears to be overvalued. The current stock price of $4.52 is trading 50.7% above its estimated GF Value™ of $3.00. GuruFocus considers Exagen to be Significantly Overvalued.

Key valuation signals for XGN:

  • Short Interest:
  • GF Value™: $3.00 vs. price of $4.52 (50.7% above fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the XGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Exagen Business Description

Other Exchanges E08A:Germany
Address 1261 Liberty Way, Vista, CA, USA, 92081
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
58GF Score

Get the complete analysis for XGN

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.52
Price
$3.00
GF Value